top of page

New Company Developing Immune Therapeutics for Autoimmunity and Cancer

24 May 2023

​

 

A new Australian biotech company, Resseptor Therapeutics (‘Resseptor’), has launched with an initial AU$2.25 million investment to develop new therapies targeting autoimmune diseases and cancer.

Resseptor Therapeutics Pty Ltd

info@resseptor.com

Level 35, 360 Elizabeth St

Melbourne VIC 3000

©2024 

bottom of page